002424 Stock Overview
Guizhou Bailing Group Pharmaceutical Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Guizhou Bailing Group Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥3.73 |
| 52 Week High | CN¥8.35 |
| 52 Week Low | CN¥2.98 |
| Beta | 0.43 |
| 1 Month Change | -7.44% |
| 3 Month Change | 3.90% |
| 1 Year Change | -54.01% |
| 3 Year Change | -50.92% |
| 5 Year Change | -57.22% |
| Change since IPO | -11.65% |
Recent News & Updates
There's No Escaping Guizhou Bailing Group Pharmaceutical Co., Ltd.'s (SZSE:002424) Muted Revenues Despite A 26% Share Price Rise
Nov 13
Does Guizhou Bailing Group Pharmaceutical (SZSE:002424) Have A Healthy Balance Sheet?
Oct 24Why Investors Shouldn't Be Surprised By Guizhou Bailing Group Pharmaceutical Co., Ltd.'s (SZSE:002424) Low P/S
Aug 15Recent updates
There's No Escaping Guizhou Bailing Group Pharmaceutical Co., Ltd.'s (SZSE:002424) Muted Revenues Despite A 26% Share Price Rise
Nov 13Does Guizhou Bailing Group Pharmaceutical (SZSE:002424) Have A Healthy Balance Sheet?
Oct 24Why Investors Shouldn't Be Surprised By Guizhou Bailing Group Pharmaceutical Co., Ltd.'s (SZSE:002424) Low P/S
Aug 15Guizhou Bailing Group Pharmaceutical Co., Ltd. (SZSE:002424) Stock's 32% Dive Might Signal An Opportunity But It Requires Some Scrutiny
May 10Shareholder Returns
| 002424 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -4.4% | -1.9% | -0.6% |
| 1Y | -54.0% | -5.7% | 8.3% |
Return vs Industry: 002424 underperformed the CN Pharmaceuticals industry which returned -5.7% over the past year.
Return vs Market: 002424 underperformed the CN Market which returned 8.3% over the past year.
Price Volatility
| 002424 volatility | |
|---|---|
| 002424 Average Weekly Movement | 6.0% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.9% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 002424 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002424's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 6,582 | Min Niu | www.gzbl.com |
Guizhou Bailing Group Pharmaceutical Co., Ltd. research, develops, produces, and sells medicines in China. The company provides medicines in the form of tablets, capsules, granules, syrups, powders, pills, tinctures, sprays, lotions, and cream for cardiovascular and cerebrovascular diseases, cough, cold, pediatric, and gynecologic diseases.
Guizhou Bailing Group Pharmaceutical Co., Ltd. Fundamentals Summary
| 002424 fundamental statistics | |
|---|---|
| Market cap | CN¥5.09b |
| Earnings (TTM) | -CN¥466.78m |
| Revenue (TTM) | CN¥4.23b |
1.2x
P/S Ratio-10.9x
P/E RatioIs 002424 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002424 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.23b |
| Cost of Revenue | CN¥1.87b |
| Gross Profit | CN¥2.36b |
| Other Expenses | CN¥2.83b |
| Earnings | -CN¥466.78m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.34 |
| Gross Margin | 55.82% |
| Net Profit Margin | -11.04% |
| Debt/Equity Ratio | 51.4% |
How did 002424 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/28 02:40 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Guizhou Bailing Group Pharmaceutical Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shanshan Li | China Merchants Securities Co. Ltd. |
| Yaming Liu | Founder Securities Co., Ltd. |
| Weina Sun | Shenwan Hongyuan Securities |